Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Science

Retrieve available abstracts of 38 articles:
HTML format



Single Articles


    December 2023
  1. GOLDE TE, Levey AI
    Immunotherapies for Alzheimer's disease.
    Science. 2023;382:1242-1244.
    PubMed     Abstract available


    November 2023
  2. PILLER C
    Brain games?
    Science. 2023;382:754-759.
    PubMed     Abstract available


    October 2023
  3. PILLER C
    Probe of Alzheimer's studies finds 'egregious misconduct'.
    Science. 2023;382:251-252.
    PubMed     Abstract available


    September 2023
  4. BALUSU S, Horre K, Thrupp N, Craessaerts K, et al
    MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
    Science. 2023;381:1176-1182.
    PubMed     Abstract available


  5. SIRKIS DW, Yokoyama JS
    Role for cell death pathway in Alzheimer's disease.
    Science. 2023;381:1156-1157.
    PubMed     Abstract available


  6. AGUZZI A, Kampmann M
    Neurodegeneration enters the era of functional genomics.
    Science. 2023;381:eadk5693.
    PubMed     Abstract available


    August 2023
  7. COUZIN-FRANKEL J
    Side effects loom over Alzheimer's drugs.
    Science. 2023;381:466-467.
    PubMed     Abstract available


    July 2023
  8. ZHANG ZY, Harischandra DS, Wang R, Ghaisas S, et al
    TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
    Science. 2023;381:eadd6696.
    PubMed     Abstract available


    May 2023
  9. TRAVIS J
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science. 2023;380:571.
    PubMed     Abstract available


    April 2023
  10. PILLER C
    Report on trial death stokes Alzheimer's drug fears.
    Science. 2023;380:122-123.
    PubMed     Abstract available


  11. COUZIN-FRANKEL J
    Promising Alzheimer's therapies shrink brains.
    Science. 2023;380:19.
    PubMed     Abstract available


    January 2023
  12. COUZIN-FRANKEL J
    Alzheimer's drug approval gets a mixed reception.
    Science. 2023;379:126-127.
    PubMed     Abstract available


    December 2022
  13. COUZIN-FRANKEL J, Piller C
    Alzheimer's drug stirs excitement-and concerns.
    Science. 2022;378:1030-1031.
    PubMed     Abstract available


    November 2022
  14. PILLER C
    Whistleblower finds possible misconduct in his own papers.
    Science. 2022;378:694-695.
    PubMed     Abstract available


  15. ENDO F, Kasai A, Soto JS, Yu X, et al
    Molecular basis of astrocyte diversity and morphology across the CNS in health and disease.
    Science. 2022;378:eadc9020.
    PubMed     Abstract available


    September 2022
  16. HOFFMANN HM
    Boosting cognition with a hormone.
    Science. 2022;377:1042-1043.
    PubMed     Abstract available


    August 2022
  17. ASHE KH
    Alzheimer's target still viable but untested.
    Science. 2022;377:935.
    PubMed    


  18. SELKOE D, Cummings J
    News story miscasts Alzheimer's science.
    Science. 2022;377:934-935.
    PubMed    


  19. COOPER YA, Teyssier N, Drager NM, Guo Q, et al
    Functional regulatory variants implicate distinct transcriptional networks in dementia.
    Science. 2022;377:eabi8654.
    PubMed     Abstract available


    July 2022
  20. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    


  21. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    


  22. PILLER C
    Blots on a field?
    Science. 2022;377:358-363.
    PubMed     Abstract available


  23. ZHOU X, Sumrow L, Tashiro K, Sutherland L, et al
    Mutations linked to neurological disease enhance self-association of low-complexity protein sequences.
    Science. 2022;377:eabn5582.
    PubMed     Abstract available


    January 2022
  24. YANG Y, Arseni D, Zhang W, Huang M, et al
    Cryo-EM structures of amyloid-beta 42 filaments from human brains.
    Science. 2022;375:167-172.
    PubMed     Abstract available


    December 2021
  25. LESLIE M
    Blood condition may guard against Alzheimer's.
    Science. 2021;374:1425.
    PubMed     Abstract available


    October 2021
  26. SELKOE DJ
    Alzheimer's drugs: Does reducing amyloid work?-Response.
    Science. 2021;374:545-546.
    PubMed    


  27. THAMBISETTY M, Howard R, Glymour MM, Schneider LS, et al
    Alzheimer's drugs: Does reducing amyloid work?
    Science. 2021;374:544-545.
    PubMed    


  28. SPIRES-JONES T
    Toward a holistic model of Alzheimer'sHow Not to Study a Disease: The Story of Alzheimer's Karl Herrup MIT Press, 2021. 272 pp.
    Science. 2021;374:267.
    PubMed     Abstract available


    August 2021
  29. BLENNOW K
    Phenotyping Alzheimer's disease with blood tests.
    Science. 2021;373:626-628.
    PubMed    


  30. SELKOE DJ
    Treatments for Alzheimer's disease emerge.
    Science. 2021;373:624-626.
    PubMed    


    July 2021
  31. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    PubMed    


    June 2021
  32. SERVICK K
    Alzheimer's drug approved despite murky results.
    Science. 2021;372:1141.
    PubMed    


    December 2020
  33. NAKAMURA T, Oh CK, Liao L, Zhang X, et al
    Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
    Science. 2020 Dec 3. pii: science.aaw0843. doi: 10.1126/science.aaw0843.
    PubMed     Abstract available


    November 2020
  34. DARWICH NF, Phan JM, Kim B, Suh E, et al
    Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
    Science. 2020;370.
    PubMed     Abstract available


    October 2020
  35. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    PubMed     Abstract available


  36. SIERKSMA A, Escott-Price V, De Strooper B
    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
    Science. 2020;370:61-66.
    PubMed     Abstract available


  37. NEDERGAARD M, Goldman SA
    Glymphatic failure as a final common pathway to dementia.
    Science. 2020;370:50-56.
    PubMed     Abstract available


    August 2020
  38. SUZUKI K, Elegheert J, Song I, Sasakura H, et al
    A synthetic synaptic organizer protein restores glutamatergic neuronal circuits.
    Science. 2020;369.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.